AGP Picks
View all

DC STEM Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on DC STEM Digest.

Press releases published on September 30, 2026

Top AI Keynote Speaker & Futurist Cathy Hackl to Host Grace Hopper Celebration 2026 World's Largest Tech Event for Women
Sharing the Power Foundation Celebrates Five-Year Milestone and Announces 2026 Class of Clean Energy Fellows
37th Annual ISHI Symposium Will Feature Presentations by STRmix Scientists
Jenny McCarthy Begins Therapeutic Plasma Exchange Journey to Address Mold Toxicity and Environmental Toxins
Crosslist, Leading Software Tool For Online Sellers, Unveils Best Practices for Integrating SaaS Solutions with WooCommerce
Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Automatic Securities Disposition Plan Adopted by Xanadu Chief Operating Officer
Oculis Announces Resignation of Lionel Carnot from Board of Directors
Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference
Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock
WISeKey Reports First Half 2026 Financial Results, Accelerates Quantum and Post-Quantum Strategy and Provides Outlook
Blaize Announces Restructuring Plan to Focus Resources on Core Growth Areas
TAPI (Technology & API Services) Names Serge Rogasik CEO to lead next chapter of growth and competitiveness
Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements
Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer
Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
Abivax présentera des données sur l’obéfazimod lors de l’United European Gastroenterology (UEG) Week 2026
Progress Software Reports Fiscal Third Quarter 2026 Financial Results
Longeveron to Participate in Three Longevity/Aging Investment Conferences
Atsena Presents Positive 18-Month Results from Part A of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

DC STEM Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.